Chris LeMasters
2016
In 2016, Chris LeMasters earned a total compensation of $743.6K as Executive Vice President and Chief Business Officer at Mirati Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $20,400 |
|---|---|
| Option Awards | $640,969 |
| Salary | $79,769 |
| Other | $2,500 |
| Total | $743,638 |
LeMasters received $641K in option awards, accounting for 86% of the total pay in 2016.
LeMasters also received $20.4K in non-equity incentive plan, $79.8K in salary and $2.5K in other compensation.
Rankings
In 2016, Chris LeMasters' compensation ranked 9,622nd out of 14,075 executives tracked by ExecPay. In other words, LeMasters earned more than 31.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,622 out of 14,075 | 32nd |
Division Manufacturing | 3,727 out of 5,489 | 32nd |
Major group Chemicals And Allied Products | 1,295 out of 1,895 | 32nd |
Industry group Drugs | 1,029 out of 1,538 | 33rd |
Industry Pharmaceutical Preparations | 810 out of 1,176 | 31st |
Source: SEC filing on April 19, 2019.
LeMasters' colleagues
We found five more compensation records of executives who worked with Chris LeMasters at Mirati Therapeutics in 2016.
2016
Charles Baum
Mirati Therapeutics
Chief Executive Officer
2016
Mark Gergen
Mirati Therapeutics
Former Executive Vice President and Chief Operations Officer
2016
James Christensen
Mirati Therapeutics
Chief Scientific Officer
2016
Isan Chen
Mirati Therapeutics
Executive Vice President and Chief Medical and Development Officer
2016
Jamie Donadio
Mirati Therapeutics